The MCF-7 breast cancer cell line, which exhibits ER+ characteristics, is a widely used experimental model for investigating the molecular mechanisms of tumor progression and the evaluation of novel therapeutic agents [5]. This evidence concerns the gene ESR1 and breast carcinoma.